Japanese food inhibits development of liver fibrosis: Study

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-04-27 04:00 GMT   |   Update On 2023-04-27 07:39 GMT

There is a scoring system named "the 12-component modified Japanese Diet Index (mJDI12)," which focuses on the intake of the Japanese diet pattern. It includes 12 foods and food groups: rice, miso soup, pickles, soy products, green and yellow vegetables, fruits, seafood, mushrooms, seaweed, green tea, coffee, and beef and pork. Scores range from 0 to 12, with higher scores indicating a diet that conforms to the Japanese food pattern.

Japanese food is popular worldwide and so much that it has been registered as a UNESCO Intangible Cultural Heritage.

A research group led by Dr. Hideki Fujii M.D. and Associate Professor Yoshinari Matsumoto at the Osaka Metropolitan University analyzed the relationship between meals rated by mJDI12, muscle mass, and liver fibrosis progression in 136 patients with nonalcoholic fatty liver disease (NAFLD) attending the Osaka Metropolitan University Hospital.

Advertisement

The research group found the following: the group with a higher mJDI12 showed a lower degree of liver fibrosis progression. Moreover, among the Japanese diet patterns, a high intake of soy products, seafood, and seaweed showed a suppressive effect on liver fibrosis progression. In addition, the group with a higher intake of soy products had higher muscle mass, and the group with higher muscle mass had a lower degree of liver fibrosis progression.

“This study indicates that the Japanese diet pattern may be effective as a dietary treatment for NAFLD patients. We hope that further intervention studies will lead to the establishment of an effective diet for those patients,” concluded Professor Matsumoto.

Their findings were published in Nutrients.

Reference:

Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease,Nutrients,DOI 10.3390/nu15051175

Full View
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News